Latest News

Yunji Announces Changes in Management

HANGZHOU, China, July 3, 2025 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced that Mr.Yeqing Cui, has resigned as Senior Financial Director and finance in charge of the Company for personal reasons, effecti...

2025-07-03 18:30 3281

MOTE Therapeutics Taps MaryJane Rafii as Chief Investment & Business Officer to Drive Global Growth of RNA Delivery Platform

BOSTON, July 3, 2025 /PRNewswire/ -- MOTE Therapeutics (referred as MOTE), a seed-stage biotech developing targeted RNA delivery solutions, announced the appointment ofMaryJane Rafii, PhD, MBA, as Chief Investment and Business Officer. The move comes as MOTE accelerates development of its MOBILIZ...

2025-07-03 18:07 2671

So-Young Regains Compliance with Nasdaq Minimum Bid Price Requirement

BEIJING, July 3, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform inChina connecting consumers with online services and offline treatments, today announced that it has received a written compliance notification f...

2025-07-03 17:00 4755

Modlily Launches "Summer of Self-Love" BOGO Campaign, Celebrating Confidence Through Fashion

LOS ANGELES, July 2, 2025 /PRNewswire/ -- International women's fashion brand Modlily—known for affordable, body-positive apparel—today launched its seasonal "Summer of Self-Love" Buy One, Get One (BOGO) Free promotion. From  July 1 through July 20, customers can refresh their summer wardrobes wit...

2025-07-03 15:54 2436

Akeso's First Bispecific ADC (Trop2/Nectin4 ADC) Enters Clinical Trials, Strengthening Leadership in 'IO+ADC' 2.0 Strategy

HONG KONG, July 3, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") has announced the successful enrollment of the first patient in its Phase Ia clinical trial for AK146D1, a bispecific Antibody-Drug Conjugate (ADC) targeting Trop2 and Nectin4. AK146D1 is Akeso's first bispec...

2025-07-03 14:46 2735

Andrés Iniesta, ambassador of fair play with MelBet

MADRID, July 3, 2025 /PRNewswire/ -- International company MelBet has announced a partnership with one of the best midfielders in football history – Barcelona legend, World Cup winner and two-time European champion Andrés Iniesta. The foundation for a productive partnership is the parties' desire...

2025-07-03 14:00 3145

Wei Zhou Named Among Caijing Magazine's Top 50 Global Chinese Venture Capitalists

PALO ALTO, Calif., July 3, 2025 /PRNewswire/ -- Recently, the prestigious media platform Caijing Magazine officially unveiled its "Top 50 Global Chinese Venture Capitalists" list.Wei Zhou, Founding Managing Partner of Cyber Creation Ventures (CCV), earned a coveted spot on the list thanks to his ...

2025-07-03 12:07 3191

MiniTool Released Video Converter 4.3 with New Features

VANCOUVER, BC, July 2, 2025 /PRNewswire/ -- MiniTool Software Limited has released a new version of its video conversion tool – MiniTool Video Converter 4.3. This update brings a new video compression feature and optimizes the interface. Upgrade Highlights in MiniTool Video Converter 4.3 * ...

2025-07-03 09:53 2313

Dizal's ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

* ZEGFROVY is the only approved targeted oral treatment for NSCLC with EGFR  exon20ins * Approval follows the U.S. FDA's Priority Review and is supported by the pivotal WU-KONG1 Part B study, in which ZEGFROVY demonstrated statistically significant and clinically meaningfulbenefits to patien...

2025-07-03 08:08 2903

Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001

Highlights: * Neurizon® Therapeutics and Elanco Animal Health enter into an exclusive global licensing agreement * Provides worldwide rights for Neurizon to utilise Elanco's intellectual property, providing exclusive access to an extensive package of non-clinical studies and manufacturing da...

2025-07-03 07:09 3530

Ascletis Announces First Participants with Obesity or Overweight Dosed in a U.S. 13-week Phase IIa Study of Small Molecule Oral GLP-1R Agonist ASC30

-  First participants with obesity or overweight with at least one weight-r elatedcomorbidity have been dosed in a U.S. 13-week Phase IIa study of small m oleculeoral GLP-1 receptor agonist ASC30. -  ASC30 oral once-daily tablet demonstrated up to 6.5% placebo-adjusted mean  body weight reduction f...

2025-07-03 07:00 2549

TROOPS, Inc. (Nasdaq: TROO) Announces Update on Hong Kong High Court Judgment and Explores Strategic Legal Options to Safeguard Shareholder Interests

HONG KONG, July 2, 2025 /PRNewswire/ -- TROOPS, Inc. (Nasdaq: TROO) (the "Company" or "TROOPS") today announced that the Company has received a judgement (the "Judgement") issued by the High Court of Hong Kong Special Administrative Region Court of First Instance in connection with the action no....

2025-07-03 04:30 5233

FiEE, Inc. Acquires Advanced Tech Suite Expected to Supercharge IoT-AI Content & Audience Targeting Platform

HONG KONG, July 2, 2025 /PRNewswire/ -- FiEE, Inc. (NASDAQ:MINM) ("FiEE" or the "Company"), a technology company integrating IoT, connectivity and AI to redefine brand management solutions in the digital era, is pleased to announce that onJune 30, 2025, it entered into an asset purchase agreement...

2025-07-03 04:30 4803

Upgrade Your Water Experience: Waterdrop's Biggest Prime Day Deals Now Live

Save more on award-winning filtration systems from July 2-13 LOS ANGELES, July 2, 2025 /PRNewswire/ -- Waterdrop Filter , a leading innovator in water purification, is l...

2025-07-03 01:00 3712

SeekInClarity: Blood-Based Multi-Omics Test Offers Promising Advance in Monitoring Cancer Treatment Response

SAN DIEGO, July 2, 2025 /PRNewswire/ -- A new prospective study published in BMC Cancer demonstrates that a novel blood-based multi-omics test, SeekInClarity, can accurately assess and predict therapeutic outcomes in lymphoma patients across different subtypes—potentially transforming how clinic...

2025-07-02 23:00 2376

Boqii Holding Limited Announces Update on Substitution Listing and 1-for-160 Reverse Split

SHANGHAI, July 2, 2025 /PRNewswire/ -- As Boqii Holding Limited ("Boqii" or the "Company") (NYSE American: BQ) previously announced, the Company plans to cease the listing of the American Depositary Shares (the "ADSs") representing its Class A ordinary shares of par valueUS$0.001 each on the  NYS...

2025-07-02 22:48 5467

Poposoap's DIY Garden Fountains Offer Backyard Calm Just in Time for Prime Day

From wine barrels to full backyard builds, Poposoap's nature-inspired DIY fountains offer an easy way to bring movement, light, and life to any space NEW YORK, July 2, 2025 /PRNewswire/ -- As more people look to slow down this summer,Poposoap

2025-07-02 21:00 2090

LalaMira Dresses for the Most Precious Firsts: Baptism and First Birthday Moments

NEW YORK, July 2, 2025 /PRNewswire/ -- Childhood is filled with fleeting yet unforgettable moments, and among the most cherished are a baby's first birthday and their baptism ceremony. These events are more than milestones—they are emotional, once-in-a-lifetime celebrations of life, love, and new...

2025-07-02 21:00 2285

Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis

SEOUL, South Korea, July 2, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced a collaboration with Microsoft to accelerate the delivery of AI-powered healthcare solutions. In conjunction with their recent acquisition of V...

2025-07-02 21:00 2799

Beatbot Announces Prime Day Deals on Award-Winning AquaSense 2 Pool Cleaning Robots

RICHMOND, Texas, July 2, 2025 /PRNewswire/ -- Beatbot , a global leader in cutting-edge robotic pool cleaning technology, is thrilled to announce exclusive Prime Day deals on i...

2025-07-02 21:00 3081

Week's Top Stories